FRESH-PEF3956-en
Genetic Polymorphism in Subjects with Type 2 Diabetes and Diabetic Nephropathy: Study “DIAB’2-NEPHRO-GENE” (DIABète de type 2, NEPHROpathie et GENEtique)
D2NG
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data']
Individuals
| Topic | Vocabulary |
|---|---|
| Endocrinology | health theme |
| Nephrology | health theme |
| Type 2 diabetes mellitus | cim-11 |
| Biological determinants: Genetic predisposition | health determinant |
| Healthcare system determinants: Use of care | health determinant |
| Behavioral determinants: Eating habits | health determinant |
| Biological determinants | health determinant |
| Healthcare system determinants | health determinant |
| Behavioral determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Individuals included in the study are adult subjects who have given their signed informed consent and covered by a social security scheme or registered with a likewise scheme. We wish to include different subjects with type 2 diabetes in the DIAB2-NEPHRO-GENE study that can be divided into three groups: 1 - Case-control subjects (with no diabetic nephropathy) - subjects with diabetic retinopathy, regardless of stage - known type 2 diabetes for more than 5 years - normal urinary albumin excretion (UAE) (defined as urinary albumin concentration strictly below 20 mg/l or 30 mg/24h), twice occurring out of 3 consecutive samples over the last 5 years. - Normal UAE in the absence of conversion enzyme inhibitor or angiotensin II antagonist receptors - creatinine strictly less than 150M.2 - Case subjects (with diabetic nephropathy): - subjects with diabetic glomerulopathy confirmed by renal biopsy, even with absence of retinopathy - or subjects with the following characteristics: - diabetic retinopathy regardless of stage. - known type 2 diabetes for more than 5 years - abnormal urinary albumin excretion (UAE)(defined as urinary albumin concentration higher or equal to 20 mg/l or 30 mg/24h), twice occurring out of 3 consecutive samples over the last 5 years - with or without change to renal function (defined by creatinine higher than 150 µmol/l, or need for extra-renal purification or renal transplantation). - absence of kidney disease other than diabetic nephropathy 3 - known type 2 diabetes for at least 5 years (recent diabetes) regardless of urinary albumin excretion or creatinine","clusion_E":""}
| Name |
|---|
| Michèle;GROSDENIER |
| Name | Role |
|---|---|
| CENTRE HOSPITALIER UNIVERSITAIRE DE POITIERS | sponsor |
| Name |
|---|
| AGENCE FRANCAISE DE DEVELOPPEMENT (AFD) |
| GROUPT ETUDE MALADIES METABOLIQUES SYST. (GEMMS) |
| MINISTERE DU TRAVAIL, DE LA SANTE, DES SOLIDARITES ET DES FAMILLES |
| SOCIETE FRANCOPHONE DU DIABETE |
| Agency name |
|---|
| Other |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2001-01-01 | 2012-01-01 |
Send request to the scientist in charge
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
| Name | |
|---|---|
| Samy;HADJADJ | samy.hadjadj@gmail.com |
| Michèle;GROSDENIER | michele.grosdenier.bruneau@chu-poitiers.fr |